Stay updated on Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.

Latest updates to the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe date on the webpage has been updated from February 27, 2025, to March 10, 2025.SummaryDifference0.7%
- Check18 days agoChange DetectedThe date on the webpage has been updated from February 24, 2025, to February 27, 2025.SummaryDifference0.3%
- Check25 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a future date has been added.SummaryDifference6%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check47 days agoChange DetectedThe website has been updated to version 2.14.2 on January 27, 2025, following the removal of version 2.14.1 on January 13, 2025.SummaryDifference0.7%
- Check61 days agoChange DetectedThe website has been updated to version 2.14.1 on January 13, 2025, following the removal of version 2.14.0 on January 9, 2025.SummaryDifference0.7%
Stay in the know with updates to Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.